Use of Platelet-Rich Plasma (PRP) Injections to Improve Knee Pain and Function Among Patients with Osteoarthritis

Principal Investigator:

Dr. Tay Boon Keng

M.B.B.S., University of Singapore

FRCS, Royal College of Surgeons, Edinburgh

FAMS, Academy of Medicine, Singapore

FACS, American Collage of Surgeons

Dr. Tay is Emeritus Consultant and Orthopedic Surgeon at Singapore General Hospital.  He has gained expertise in hospitals and medical centers in both Singapore and abroad and has a special interest in knee surgery.  Dr. Tay also has diverse experience leading teams of doctors, nurses and allied health specialists for medical and academic exchanges with overseas medical institutes, with the aim of nurturing these medical professionals to excel in their field of expertise.

Study Abstract:

Intra-articular PRP injections have been shown to alleviate pain and improve function for 6 months for patients with knee osteoarthritis (OA).  Despite the long-standing efficacious use of PRP injections, the use of PRP for knee OA is a relatively new treatment option for patients residing in the Republic of Singapore.  This Circle unites Singaporean orthopedic surgeons in the standardization of effectiveness and safety of PRP injections for knee OA.  This Circle captures patient-reported data related to knee pain, function, and stiffness prior to and following a one-time treatment of PRP for 12 months.  The Circle also collects clinically pertinent data to inform clinical decision-making.

Study Type:

Interventional, Quality Improvement

Circle Benefits:
  • Longitudinal, real-world safety and efficacy assessment of PRP.
  • Global collaboration with orthopedic surgeons.
  • Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications.
Real-World Data Surveys:

Western Ontario and McMaster Universities Arthritis Index (WOMAC)

Circle Type:

Private Circle

Interested in learning more about this Circle?
Additional Resources:

Use of Platelet-Rich Plasma (PRP) Injections to Improve Knee Pain and Function Among Patients with Osteoarthritis

Circle Objective Abstract:

Intra-articular PRP injections have been shown to alleviate pain and improve function for 6 months for patients with knee osteoarthritis (OA).  Despite the long-standing efficacious use of PRP injections, the use of PRP for knee OA is a relatively new treatment option for patients residing in the Republic of Singapore.  This Circle unites Singaporean orthopedic surgeons in the standardization of effectiveness and safety of PRP injections for knee OA.  This Circle captures patient-reported data related to knee pain, function, and stiffness prior to and following a one-time treatment of PRP for 12 months.  The Circle also collects clinically pertinent data to inform clinical decision-making.

Real-World Data Surveys:

WOMAC

Intervention:

Circle Benefits:
  • Longitudinal, real-world safety and efficacy assessment of PRP.
  • Global collaboration with orthopedic surgeons.
  • Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications.

Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration

Circle Type:

Private Circle

Supporting Materials
Interested in learning more about this Circle?

CIRCLE LIBRARY

CIRCLE NAME

Total Knee Arthroplasty Outcome-Based Performance Measure

SURVEYS

OUTCOMES SURVEYS

VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)

CLINICAL SURVEYS

As specified by Provider

THIS CIRCLE IS FOR:

Provider Receiving CMS Reimbursement For TKAs

CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.

Other Providers Performing TKAs

Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.

WHY CIRCLES

Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Easily export to, integrate with, existing systems
Robust reporting functions
Illustrative Materials
Minimal administrative and clinical burden
Accommodates surgical variations
All data accessible 24/7 from any device
Allows extensive customization
Inherent collaboration among peers
Improves clinical decision-making
Adjustable outcomes alerts
Regular reports on key metrics
Automatic patient consent capture
Illustrative Materials
Sustained onboarding and follow-up processes
Communication of condition and protocol education materials *
Regular progress reports *
Cohort comparisons *
Newsletters, other patient communications *
*  Provider defined
Illustrative Materials
Clear ownership of validated anonymized datasets
Copyrightable
Right to publish
Right to monetize
Illustrative Materials
Not a point solution, but a strategic initiative
Easily extensible and scalable
Accommodates Health Equity initiatives
Accommodates CMS Hospital Value Program and other Value-Based Care initiatives
Clinical Grade
Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Robust reporting functions
Easily export to, integrate with, existing systems
Interested in this Circle?

If you have any questions, please contact us.

ADDITIONAL RESOURCES